Extracapsular nodal extension and tumor deposits in head and neck squamous cell carcinoma

Author:

González‐Vallejo Leyre1ORCID,Blanco‐Sainzdelamaza Javier2ORCID,Querejeta‐Ayerra Arrate1ORCID,Chiesa‐Estomba Carlos3ORCID

Affiliation:

1. Radiotherapy Department Donostia University Hospital San Sebastian Spain

2. Medical University of Bialystok Bialystok Poland

3. Department of Otorhinolaryngology and Head and Neck Surgery Donostia University Hospital San Sebastian Spain

Abstract

AbstractBackgroundTumor deposits (TDs) are an infrequently mentioned feature of head and neck squamous cell carcinoma (HNSCC) that are currently grouped under extranodal extension (ENE) in the AJCC 8th edition of HNSCC TNM staging. The prognostic implication of TDs in comparison to ENE remains uncertain.MethodsThis observational, retrospective, non‐randomized study evaluated patients with HNSCC who underwent initial surgical resection, with neck dissection and adjuvant radiotherapy ± chemotherapy. Clinical variables were considered, and statistical analyses were conducted to compare time progression and overall survival (OS) in patients with TDs against those with ENE.ResultsOf the 71 patients included in the study, 50 were diagnosed with ENE (pN2a‐ENE in 38 patients and pN3b‐ENE in 12), while 21 had TDs ± ENE. The median time to progression was significantly different based on the presence of ENE or TDs (p = .002) and pN2a‐ENE/pN3b‐ENE or TDs (p = .007). The three‐year OS was 55.7% for the entire group, 60.4% in ENE and 38.4% in TDs (p = .021). The OS difference between the pN2a‐ENE, pN3b‐ENE, and the TDs group was also significant (p = .05). The hazard ratio between ENE and TDs was Exp (B) 4.341 (p = .044).ConclusionsTDs in HNSCC are associated with a lower OS than ENE, despite intensified adjuvant therapy. Our results confirm a better prognosis for pN2a‐ENE vs. pN3b‐ENE, and pN3b‐ENE vs. TDs. TDs may serve as an indicator of poor prognosis and require separate TNM classification in HNSCC staging. Larger studies are needed to evaluate TDs impact on treatment strategies and outcomes.

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3